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Abstract: The pharmacophore properties of a new series of potential purinoreceptor (P2X) inhibitors
determined using a coupled neural network and the partial least squares method with iterative
variable elimination (IVE-PLS) are presented in a ligand-based comparative study of the molecular
surface by comparative molecular surface analysis (CoMSA). Moreover, we focused on the
interpretation of noticeable variations in the potential selectiveness of interactions of individual
inhibitor-receptors due to their physicochemical properties; therefore, the library of artificial dipeptide
receptors (ADP) was designed and examined. The resulting library response to individual inhibitors
was arranged in the array, preprocessed and transformed by the principal component analysis (PCA)
and PLS procedures. A dominant absolute contribution to PC1 of the Glu attached to heptanoic gating
acid and Phe bonded to the linker m-phenylenediamine/triazine scaffold was revealed by the PCA.
The IVE-PLS procedure indicated the receptor systems with predominant Pro bonded to the linker and
Glu, Gln, Cys and Val directly attached to the gating acid. The proposed comprehensive ligand-based
and simplified structure-based methodology allows the in-depth study of the performance of peptide
receptors against the tested set of compounds.
Keywords: artificial dipeptide library; PX2 inhibitors; IVE-PLS; CoMSA; stochastic model validation
1. Introduction
Drug discovery is a complex process that is focused on the optimization of the molecular
interactions between a drug molecule and a biomolecular target. The contacted drugs or,
more generally, ligands (in Latin ‘ligare’ means ‘tie’) and macromolecules initiate the signals
that control substantial effects of living organisms [1]. Finding balance between expected hit
→lead→seed→drug candidate potency and its ADMET-related properties to identify high-quality
marketed drug molecules seems like searching ‘a needle in a haystack’ that lurks behind the
complex property space that is delimitated by the complex nature of ligand-target interactions,
which are ruled by inter-/intra-molecular phenomena [2,3]. In order to discard compounds that have
undesirable biological/physicochemical features according to the ‘fail-early fail-cheaply’ paradigm
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and to reach more successful ‘stories’ in rational drug design, the quantitative conversion of the
structural/feature-based descriptors into an ADMET-tailored molecular potency is highly desirable
as a ‘heuristic guide’ that relates the in vitro or in vivo parameters to calculable physicochemical
properties [4]. A key question that confronts computational chemists is how to quantitatively transform
a myriad of feature-based descriptors a priori calculated for the compounds into ADMET-related
molecular potency. From among optimistic approaches, modelling multidimensional quantitative
structure-activity relationship (mD–QSAR) techniques seem to be pragmatic provided that a congeneric
series of compounds is processed [5]. Conceptually, a classical QSAR strategy is based implicitly
or explicitly on the principle of similarity, where ‘congeneric’ series of molecules show similar
pharmacological profile [6]. On the other hand, a variety of observed guest-host interactions is
a potential pitfall while modulating desired ADMET-related properties. Simple Hantzsch-type
descriptors are not often sufficient to provide the ‘physically realistic’ descriptive and/or predictive
rules how to ‘navigate’ through factual/virtual chemical space (CS = FCS∪VCS). Hence, the ‘indirect’
ligand-based and ‘direct’ protein-based multidimensional in silico protocols produce informative
descriptors to capture more interpretable SAR trends potentially useful in the optimization phase of
the novel drug candidates.
In receptor-independent (RI) procedures, the ‘reverse image’ of the target binding geometry is
provided in the form of pharmacophore maps displaying the spatial arrangements of crucial guest-host
interaction patterns. Typically, ligand-based 3D methods employ the comparison of molecular shape,
since molecules can be characterized as having ‘skin’ of a particular thickness. In particular, 3D-QSAR
shape-based methodologies with a classical comparative molecular field analysis (CoMFA) and
comparative molecular surface analysis (CoMSA) diffused quickly into computational/medicinal
chemistry getting more and more popular in the drug design area [7]. In receptor-dependent (RD)
approaches, specific requirements for efficient guest-host interactions are deduced directly from the
protein-binding cavity in target-guided QSAR procedures [8]. Considering long-term aspiration,
these ligand-based procedures should be combined with structure-based ones or homology models in
order to retrieve a detailed insight into mutual drug-target interactions.
In absence of an empirically specified receptor structure, a valid estimation of the host binding
geometry should be supplied using flexible sensors or molecular probes [9]. It seems that a set of
artificial receptors (AR) can compose a diagnostic platform capable to selectively interact with small
chemical reagents under controlled conditions [10]. In consequence, a natural question appears about
preferable combinations of building blocks that comprise a ligand and/or a target structure. Is it
possible to tailor theoretically and/or empirically a protein cavity to enhance the target druggability
in fragment-based domain design? Generally, comprehensive answers to the above questions still
exceed our capabilities despite many efforts directed towards this issue. In response to this pressure,
the potential of artificial receptors that are smaller and therefore structurally less complicated by
definition as a model system has been reported recently [11]. In fact, the ensemble of artificial
biosensors formed by N-lipidated peptides immobilized on cellulose was arranged in the form of
a probe matrix to recognize the ligand shape, size and polarity [12]. Due to high peptide and lipid
fragment flexibility, the shape, size and polarity of the binding cavity can be adequately adjusted
reflecting the induced fit phenomenon observed in real biological systems; however, the extremely
simplified fragment-based representation of an artificial cleft emphasizes the more local nature of
the intricate drug-receptor recognition pattern in physiological fluids. The allocation of various
structural and physicochemical attributes corresponding to hydrogen bond donors/acceptors and
lipophilic motifs supplemented with pi-donors/acceptors enabled to form a linear structure, namely
a matrix of podands in such a way that a flexible N-lipopeptide fragment is preceded by relatively
rigid aromatic rings. In other words, the binding cleft comprises tethered fragments of walls that are
generated from aromatic rings expanded with a flexible peptide fragment and closed with the lipophilic
chain of lipidic zipper creating a molecular trap to effectively match a guest molecule. The regular
pattern of immobilized podands on the surface of the solid carrier not only generates a multitude of
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feature library components by themselves, but also provides data about the relationships between
them [13]. A comprehensive target-guided guest response can work as a diagnostic fingerprint useful
in monitoring changes of the structure-affinity pattern.
In fact, the most challenging are attempts to rationalize interactions with an unknown molecular
target. For classic bi-functional alkylating nitrogen mustards, anticancer activity is associated with
the process of crosslinking of DNA strands [14,15]. Our studies on mono-, di-, and tri-functional
mustards attached to the triazine ring revealed that the first ones are the most active among
them [16,17]. Obviously, mono-functional alkylating agents cannot be engaged in the cross-linking
process. A strongly diversified mode of action proposed for the anticancer agent constructed on
the 1,3,5-triazine scaffold prompted us to perform preliminary SAR studies using the library of
randomized receptors that were prepared using all proteinogenic amino acid residues [18]. After the
analysis of interactions between ligands and receptors that strongly bind the most active of them,
a set of the preferred amino acid residues was specified. The identified residues can be useful
while screening active sites of already known targets of anticancer triazine derivatives. Moreover,
experimental findings can provide clues to the composition of the molecular target for mono-alkylating
(2-chloroethyl) triazine derivatives. In the case of 2,4,6-triamino-1,3,5-triazine derivatives with various
amino substituents, the proposed mechanism of action represents an interaction with the active cleft of
ATPase, DNA topoisomerase IIα or p21-activated kinase 4 [19–21]. Considering that the suggested
activity of 2,4,6-triamine-1,3,5-triazine derivatives is associated in most cases with enzymes/receptors
crucial for building blocks of nucleic acids or energy carriers also containing a purine moiety, it is
suspected that the 2,4,6-triamine-1,3,5-triazine core may mimic this heterocyclic ring. One of such
receptors could be a P2X receptor—a membrane receptor present in cells of the variety of tissues.
P2X receptors represent new therapeutic targets forming non-selective cation channels with a unique
trimeric architecture gated by extracellular ATP [22–24]. In response to ATP binding, the receptor
conformation is switched from ‘closed’ to ‘opened’ allowing the permeation of ions (especially Ca2+)
through the membrane that leads to the depolarization of cells. In fact, P2X receptors mediate a variety
of physiological processes (e.g., neuro/immunomodulation, inflammation, synaptic transmission);
therefore, the development of novel therapeutic agents targeting the binding pocket is valid from the
point of view of anticancer activity.
There were two principal objectives of the current investigation. First, it is of interest to perform a
ligand-based investigation with a comparative study of molecular surface using comparative molecular
surface analysis (CoMSA) to produce a pharmacophore pattern for a new set of 20 derivatives as
potential anticancer agents. On the other hand, it should be strongly emphasized that we focused more
on the development of ‘descriptive’ pharmacophore models within the congeneric series of compounds
than ‘predictive’ rules with strictly specified domain of applicability; however, the similarity of
compounds was scrutinized using the principal component analysis (PCA) approach for the pool
of generated descriptors. The probabilistic pharmacophore geometry using the stochastic model
validation (SMV) approach indicated the relevant contributing factors for the anticancer agent activity
profile. Secondly, we focused on the interpretation of noticeable variations in the potential selectiveness
of individual inhibitor-receptor interactions; therefore, the combinatorial library of artificial dipeptide
receptors (ADR) was designed, synthesized, empirically examined and arranged in the form of a probe
matrix in the pseudo structure-based examination of ligand responses.
2. Results and Discussion
2.1. Library of Docked Anticancer Active Triazine Derivatives
The collection of docked anticancer active triazine derivatives was split into various (sub)groups
taking into account the chemotype of the compounds (alkyl, aromatic, cyclic), their lipophilic character
(logP ≤ 5, logP > 5) and activity profile (active, non-active) as shown in Table 1. The general
pattern of the anticancer compounds comprises the N-(2-chloroethyl)piperazine moiety and, in the
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overwhelming amount, a methoxy substituent on the triazine ring [13,16,17]. The third substituent of
the triazine ring was amine, amino acid and peptide derivatives. With the exception of compounds
15 and 20, all tested molecules contained two amino substituents mimicking the structure of
2,4,6-amino-1,3,5-triazine derivatives with various amino substituents. Compounds were divided
into the following chemotypes: derivatives containing aromatic amine residues (1–3), aliphatic
amines (4–6), amino acid residues (7–9, 17, 18), dipeptide derivatives (10, 12, 13, 19) and derivatives
containing two moieties N-(2-chloroethyl)piperazine and aromatic amine residues (14, 15, 20) or
the methoxy substituent (11, 16). The investigated compounds can also be subdivided in relation
to the hydrophobicity and hydrophilicity. Derivatives containing amino acid residues/dipeptides
showed increased polarity in comparison to derivatives containing aromatic or aliphatic (cyclic and
acyclic) substituents.
Table 1. Structure and activity of host molecules [13,16,17]. IC50 values were determined experimentally
on the MCF-7 cell line.
Comp. Compound Structure IC50 [µM] Comp. Compound Structure IC50 [µM]
1
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2.2. In Silico Evaluation of In Vitro Anticancer Activity Using CoMSA and SMV Approach
The general purpose of the ligand-based examination was the comparative shape analysis via
molecular surface variations (electrostatic/steric features) using the CoMSA approach to model
in vitro activity observed for the new set of 20 derivatives as potential anticancer agents. Hence,
we investigated the pharmacophore properties of the target series using a coupled neural network
and the partial least squares method (PLS) with iterative variable elimination (IVE). The outcomes
of inhibiting potency modelling (IC50) were correlated with surface descriptors considering multiple
training and test subsets or (in)dependent variables used. Unfortunately, the performance of the
inhibitory profile for the entire set of molecules in the training dataset is not satisfactory for CoMSA
models (q2cv < 0.5), irrespective of the map size (20 × 20–50 × 50). A question appears regarding the
relevance of simulated and real model predictability that cannot be only tested by simple assessment
of data fitting. Consequently, we performed external validation with splitting the molecule subset
into a set of training/test collections to evaluate the model predictive ability with SDEP and q2test
statistics. The CoMSA performance for models divided arbitrarily into training/test subsets in 2:1
ratio (14/6) ranked according to the molecule inhibitory activity (IC50) was scrutinized as well. In all
cases, the best q2cv/q
2
test outcomes indicated fairly poor model abilities accompanied with low model
predictive power. Moreover, we employed the Kennard-Stone algorithm on the dependent variable
to divide representatively the ensemble of data into training/test subsets; however, the statistical
characteristics of CoMSA models were not noticeably improved. The obtained findings confirmed
that the division of objects into training/test subgroups having a restricted set of molecules, for which
activity data are available a priori, is not a trivial issue, and a model with predictive capability should
by all means characterize SAR relations inherent in the test set. Accordingly, an additional approach,
namely SMV, has been used as a kind of perturbation procedure to examine the structure of data.
Hence, we investigated the variations of the statistical estimators during CoMSA inhibitory activity
modelling, as the initial population of 20 molecules was recurrently sampled into 14/6 training/test
subseries (fraction 2/3 to 1/3). Usually, the inspection of all possible combinations is resource/time
demanding; however, in this case, it was technically viable to inspect the whole pool of systematically
generated training/test populations (C620 ≈ 4 × 104). The observed profile for q2cv vs. q2test distribution
confirms the intuitive interpretation of the q2cv/q
2
test fluctuation pattern where the regions of higher
modelling ability within the training set can be depicted for the pIC50 profile (q2cv ≥ 0.75). Obviously,
the preferential selection of molecules into the training set, which easily fit into the model, can be
accompanied with a decrease in the predictive power for the remaining ones, which confirms the
dichotomic nature of q2cv/q
2
test parameters, where a high value of q
2
cv does not automatically imply
high model predictability [25]. In consequence, we should beware of q2, because the great advantage
of the QSAR/QSPR paradigm does not lie in extrapolation [26]. The compound selection into the
training/test subsets was investigated, while sampling the best CoMSA models (q2cv ≥ 0.75), indicating
the test molecules (9, 10, 13–15, 17) that disrupt the modelling efficiency. Consequently, the comparative
molecular field analysis (CoMFA) and CoMSA performance for models divided according to the
specified training/test selection improved considerably (q2cv = 0.66 vs. q
2
cv = 0.72).
Drug-likeness is an idea that drug compounds differentiate from other molecules in their physical
properties; therefore, a priori calculation of molecular descriptors (topological descriptors, structural
fingerprint keys and other properties) is crucial for compound’s bioavailability and, hence, critical
for the prospective drug candidate. Hence, a PCA technique for an ensemble of descriptors derived
using Dragon 6.0 package was employed to the analysed compounds. All columns with constant or
nearly constant values (standard deviation < 10−4) and with missing values have been eradicated
from the initial number of selected parameters (4885) at the pre-processing stage resulting in the final
set of 2797 descriptors. The final dataset was arranged in matrix X20×2797 with rows representing
molecules (called objects) and columns representing numerical parameters (called variables) for
further analysis. The efficient investigation of (dis)similarities between the studied objects requires
simultaneous consideration of all calculated parameters. Thus, PCA was employed to visualize
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relevant differences in the performance of investigated molecules with respect to their structure and
inhibitory profile. The analysis was performed for centred and standardized data, since the studied
data library includes parameters of various orders of magnitude. The percentage of modelled variance
was applied in the determination of the number of significant components (PCs). The PCA model with
first three PCs described 79.78% of the total data variance, while the first two PCs accounted for 72.79%.
Projecting objects on the planes defined by a few first principal components allows an interesting
observation of the data structure. The analysis of score plot PC1 vs. PC2 in Figure 1a indicates that,
basically, anticancer derivatives can be classified into groups according to the first principal component
(describes 57.90% of the total variance). Roughly speaking, PC1 reveals variations between objects
(molecules), where the test compounds are generally grouped together (PC1 > 20), confirming the
trends observed in CoMFA/CoMSA modelling. Noticeable variations between molecules 11 and 12
encoded by a set of descriptors (parameters) confirm their mutual structural dissimilarity. Similarly,
nine parameters (variables) calculated by the Sybyl software were gathered including count, volume,
surface, Lipinski’s rule of five (Ro5) and lipophilicity descriptors (Table S1 in Supplementary Materials)
to investigate variations within the ensemble of 20 anticancer derivatives. The compression of data
slowly increased with the number of PCs that were included. The first two PCs account for 86.28% of
the total data variance and it increases to ca. 93.28% for the third PC. The projection of objects on the
plane defined by PC1 vs. PC2 component (Figure 1b) confirmed the tendency observed previously
to cluster compounds of the test subpopulation (PC1 > 0). Interestingly, distant object no. 17 can be
regarded as an outlier to the remaining ones along PC2 since it violates Ro5. Moreover, the inspection
of compound lipophilicity colour-coded accordingly to calculated values of clogP detected that objects
are clustered along PC2 (PC2 < −1) more or less according to their lipophilicity profile as illustrated in
Figure 2. The projection of variables on the plane defined by first and second loadings for Dragon and
Sybyl parameters is presented in Figure S1 (Supplementary Materials).
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defined by PC1 and PC2.
We applied the subs quent level of variable elimination in order t generate m aningful and
predictive CoMSA models. The r cursive IVE-PLS lgorithm was employed as filter to specify
structural descriptors having the highest individual weightings to the biological activity [27]. G ner lly,
a slight improvement of the q2cv performance was observed when the column from the data matrix that
is assigned with the lowest value of abs(mean(b)/std(b)) was extracted. The moment of q2cv deteri ration
indicates the number of relevant columns; therefore, the backward column elimination is recurrently
repeated, until the optimal number of variables included in the model is accomplished. A simplified
visual inspection of the generated pharmacophore pattern gives a clear 3D picture of the regions that
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should be modified to modulate the biological activity [28]. The sign of influence is colour-coded,
indicating not only regions with positive and/or negative activity contribution, but also four possible
combinations of the mean charge/correlation coefficient. The bright polyhedra in Figure 3a specifies
3D areas where an atom or a substituent is foreseen to be positioned in order to increase the activity of
the compound, while dark spheres indicate patterns detrimental for the inhibitory potency, mainly due
to steric hindrance or electrostatic factors. In particular, some regions with suggested unfavourable
contribution appear in the close proximity to the negatively charged oxygen atom and hydrogens
of the metoxy group directly attached to the triazine motif. It seems that an increase of the negative
charge on oxygen by donor substituents can be detrimental for the anticancer activities of the examined
compounds as indicated by the corresponding regression coefficient pool in Figure 3b. Moreover,
the obtained findings demonstrate the importance of the area occupied by the positively charged
hydrogen atom bonded to the nitrogen atom as a significant factor interacting non-covalently with
the macromolecular site (hydrogen bond donor). The displayed arrangement of the bright polyhedra
(Figure 3a) illustrates the significance of negatively charged atoms (mainly oxygen atoms) of the side
chain as shown in Figure 3b. From the structural point of view, electronic parameters can notably
effect the process of IC50 modulation, mainly due to inductive or resonance effects, as depicted by the
activity of molecules 8, 9, 12, 13 and 18.
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Figure 3. Molecular plots show spatial sectors of the greatest contribution to inhibitory potency retrieved
from the best CoMSA model. Colours code the sign of influence (a). Four possible combinations of
mean charge and correlation coefficient are colour-coded for charge descriptors (b). Compound 2 was
plotted as a reference molecule.
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It should be emphasised that the SMV protocol for the pharmacophore visualization based on the
CoMSA modelling with satisfactory statistical parameters provides a spatial distribution of chemical
groups/atoms potentially important for increasing/decreasing the activity profile of prospective
anticancer agents.
2.3. Probing Artificial Dipeptide Receptor Library
The general objective of this pseudo structure-based examination was the comparative study of
ligand responses from the artificial receptor library in order to probe the prospective purinoreceptor
(P2X) inhibitors. In fact, we focused on the interpretation of noticeable variations in the potential
selectiveness of individual inhibitor-receptor interactions due to their physicochemical properties.
The experimental data contains a set of responses from the artificial library for 20 probe compounds
that exhibit different structural and physicochemical properties. The library is an ensemble of artificial
receptors, each of which is a strain of two amino acids (X–Y) and lipid residues composed of heptanoic
and decanoic acids (denoted as H and D, respectively). The entire set of 20 amino acids was taken into
account in the library design for residues directly attached to carboxylic acids (X = A, R, N, D, C, Q, E,
G, H, I, L, K, M, F, P, S, T, W, Y, V), while one out of three (Y = A, F, P) was examined in the position
of binding to the linker, thus resulting in the total of 120 (2 × 20 × 3) artificial receptors. Amino acid
blocks and gating acids (clogPH = 2.41 vs. clogPD = 3.93) were selected in order to provide a fairly
robust measure for the diverse ADR constructs that should imitate a real receptor structure. These are
attached to cellulose and spatially distributed. The interaction between the examined compounds and
the library of artificial receptors is visualized using the competitive adsorption-desorption mechanism
of a reporter dye (Brilliant Black) used as an Indicator Displacement Assay, IDA and is monitored
using a Sunrise Microplate Reader with the Magellan Software [29]. A more detailed description of
the construction of the artificial receptor library is beyond the scope of this article, but can be found
elsewhere [9–13]. The data set was then prepared for further analysis; hence, it was organized into a
matrix containing 120 artificial receptor responses in columns for a set of 20 tested compounds in rows
as illustrated in Figure 4b.
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120 receptors (columns) and 20 compounds (rows).
The examination of the response value indicated that all tested compounds respo ded with
positive values resulting in colour changes. The non-direct method was used to probe the affinity
of the compounds vs. the receptor library, i.e., the library was first saturated with ligands and then
coloured with a dye preparation. The final colour was recalculated to the affinity of the compounds
vs. individual receptors as the difference with the coloration of the receptor with the reporter dye
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but without a ligand with the maximal value of 73.9 and minimal of 0.001. It seems that compounds
annotated with clogP < 2 reveal higher values of the response as shown in Figure 4a. The distribution
of the response values that were obtained for all receptors with heptanoic and decanoic gating acids
probed for the 20 ligands is presented as histograms in Figure 5.
Molecules 2018, 23, x 10 of 22 
 
acid lipophilicity profiles. Regarding the multivariate nature of the binding issue, PCA was 
employed to illustrate crucial variations in the performance of the artificial receptors with respect to 
their binding strength. The analysis was performed for centred and transposed data X120×20. The PCA 
model with three PCs described 68.53% of the total data variance, while the first two PCs ccount for 
51.98% of the total data variance. First, let us examine the influence of the receptor design with 
respect to two different lipid residues, heptanoic (H) or decanoic (D), on its binding selectivity as 
illustrated in Figure 6. 
 
Figure 5. Histogram of response values for set of receptors with heptanoic (a) and decanoic (b) gating acids. 
 
Figure 6. Projection of receptors on plane defined by first and second principal components with 
type of lipid residue (heptanoic and decanoic). 
The analysis of the score plot that was constructed as projections of the experimental data on 
the individual lipid acid indicated that, basically, these residues could be classified into two groups 
regarding their structural/lipophilic features. Accordingly, heptanoic-terminated receptors (clogPH < 
2.5) are roughly located in the area of PC1 < 0 and PC2 > 0, while decanoic ones (clogPD > 2.5) are 
evenly distributed within the rest quadrants. The largest differences in the interaction strengths 
between a probe compound and a given receptor are observed for the loadings characterized by the 
largest absolute values. Interestingly, it was noticed that along PC2, some of the largest positive 
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gating acids.
The elongation of the acid chain produces stronger guest-host interaction (the response values > 50
for 7.3% of decanoic vs. 4.2% of heptanoic gating acids) that can be roughly correlated with the acid
lipophilicity profiles. Regarding the multivariate nature of the binding issue, PCA was employed to
illustrate crucial variations in the performance of the artificial receptors with respect to their binding
strength. The analysis was performed for centred and transposed data X120×20. The PCA model with
three PCs described 68.53% of the total data variance, while the first two PCs account for 51.98%
of the total data variance. First, let us examine the influence of the receptor design with respect to
two different lipid residues, heptanoic (H) or decanoic (D), on its binding selectivity as illustrated in
Figure 6.
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of lipid residue (heptanoic and decanoic).
The analysis of the score plot that was constructed as projections of the experimental data on
the individual lipid acid indicated that, basically, these residues could be classified into two groups
regarding their structural/lipophilic features. Accordingly, heptanoic-terminated receptors (clogPH
< 2.5) are roughly located in the area of PC1 < 0 and PC2 > 0, while decanoic ones (clogPD > 2.5)
are evenly distributed within the rest quadrants. The largest differences in the interaction strengths
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between a probe compound and a given receptor are observed for the loadings characterized by the
largest absolute values. Interestingly, it was noticed that along PC2, some of the largest positive values
of loadings were yielded for probe compound 16 annotated with high receptor library responses
(see Figure 4b), especially with Lys attached to the heptanoic residue. On the other hand, compound
11 is described by a negative value on loading PC1 contributing mainly to Glu linked to heptanoic
acid. Basically, compound 11 produces a pretty poor receptor library response being annotated with
poor anticancer activity (IC50) as well. Let us now examine interaction strength as a function of the
amino acid fixed as the first and the second residues within the receptor constructed. Projections
of all receptors onto a plane defined by the first and the second scores are presented in Figure 7,
while individual amino acids fixed in positions 1 and 2 are coded by different colours.
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Figure 7. Projection of receptors on plane defined by first and second principal components with type
of first (a) and second (b) residue used to build receptor structure.
Roughly speaking, proline-based receptors are separated from the alanine/phenyloalanine
ones along PC2 > 0 (Figu e 7a) indicating structural incoherencies between these two groups of
residues—sometimes proline is named as imino cid. No clear relationship is observed for amino
acids arranged at po ition 2 that are directly attached to gating lipid r sidu ; however, basic amino
acids (Arg, His, Lys) are vag ely separated fr m the acidic and aromatic ones along PC1 as shown in
Figure 7b.
Basically, it can be expected that interactions between the target and the host ligands will be
associated with the chemical structure of the receptor and the probe compound. Therefore, structurally
similar ligands, namely, chemotypes should be retained similarly (comparable interaction strengths) by
similar receptors, while diverse ligand structures would have different binding strengths, which would
also induce dissimilar receptor answers. We also investigated the data set matrix with a collection
of testing compounds as input objects (20 × 120). In this case, the first two principal components
explained approximately 75.36% of the total data variance, while the set of three principal components
accounted for nearly 84.58%. The analysis of the score plot PC1 vs. PC2 with the indicated activity
compound profile (hA: IC50 < 25, A: 25 < IC50 < 50, IN: 50 < IC50 < 100, hIN: IC50 > 100) revealed the
potency for the separation of biotypes along PC1, where highly active (hA) and active (A) ones are
generally grouped together (PC1 > −100) as depicted in Figure 8a.
It is worth noting that compounds annotated with pretty high ADR response (9, 10, 16 and 19)
are characterized by large negative values on the first principal component (PC1 < −100) accompanied
with lower values of clogP (Figure 8b). Moreover, the examination of compound chemotypes indicates
a similar tendency, especially within the aromatic group specified by higher values of clogP as
illustrated in Figure 8c. The investigation of the corresponding loading plot showed a dominant
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absolute contribution to PC1 of Glu attached to heptanoic gating acid and Phe bonded to the linker
m-phenylenediamine/triazine scaffold. This is an important finding, since Phe is also a genuine ligand
counterpart in the natural P2X receptor [30].
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At this point, the question appeared whether it is possible to relate ADR response with the
compound activity p ofile (pIC50). We notic d the lack of correlation b tween mean/median values
of the ADR response for the entire set of compounds and their activities. Surprisingly, the similar
tendency was observed for the ADR response and compound lipophilicity profiles, even within the
biologically preferred range of 3 < clogP < 5. It seems that the gating acid behaves similarly to the cell
membrane, where ligands, the lipophilicity of which is low enough, cannot come into contact with
the high lipophilic barrier of the gating acid, while those with the exceedingly high lipophilicity are
trapped by this barrier and cannot penetrate into the ADR cleft. It seems that the library used is not a
good model of the binding clefts responsible for the biological activities measured by experimental
IC50 values, therefore tri-/tetra-peptide models should be examined in the future as well.
On the other hand, let us eliminate inactive compounds—a pretty clear relation can be observed
for molecules with higher affinity and mean values of response with the correlation coefficient r of
−0.80 and −0.87 for heptanoic and decanoic subgroups, respectively. The response values for the
above-mentioned artificial receptors were then correlated with −log(1/activity). A negative r value is
due to colour reaction that was applied—the higher the level of activity, the less intense the colour of a
probe. The largest negative, but rather low, coefficient for the heptanoyl-Glu-Ala system with r = −0.52
was revealed. Comparable results of correlation were obtained mainly for heptanoyl-Glu/Trp/Phe-Phe
(r ≈ −0.45) receptor components.
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Basically, informative variable selection is not an indispensable pre-processing procedure to prune
the input assemble of generated descriptors; however, it can indicate the combination of ADR receptors
that contribute significantly to the activity of compounds. Hence, PLS models were constructed
for the centred data with their complexity estimated by the LOO-CV procedure. Considering the
number of objects, the maximum number of PLS components was truncated to 7. Thus, columns
annotated with the highest stability for each of the randomly chosen models were identified using the
IVE-PLS methodology. In general, the elimination of a column characterized by the lowest value of the
regression coefficient from the data matrix improved q2cv until the optimal number of variables included
within the model was reached. The performance of PLS models obtained with model elimination
provided the approximate value of q2cv = 0.91 for H and D subsets. The IVE-PLS method indicated
receptor systems with predominant Pro units (fraction of selected/all among selections) bonded
to the linker, which appeared to be dominant amino acids irrespective of the receptor/compound
subseries—Ala and Phe are selected in comparable quantities. Moreover, decanoic acid selection
outperforms slightly heptanoic one, which can be related to the acid lipophilicity profile. When we
compared the selected amino acids directly attached to the gating acid, we noticed that Glu, Gln, Cys
and Val are frequently indicated as significantly contributing the anticancer activities of the analysed
compounds. Interestingly, each subset receptor retained by the IVE-PLS contained receptors that were
characterized by the highest negative correlation (activity vs. the mean value of response). In this
section, we mainly focused on the interpretation of noticeable variations in the potential selectiveness
of individual inhibitor-receptor interactions due to their physicochemical properties.
3. Experimental Section
3.1. CoMFA Analysis
Comparative molecular field analysis (CoMFA) is a well-known methodology capable of
simulating the influence of molecular shape on modelling steric (Lennard-Jones) and electrostatic
(Coulomb) fields as important intermolecular interactions involved in non-covalent ligand-receptor
binding [31]. Basically, the CoMFA approach is based on the assumption that the comparative
analysis of spatial patterns generated within the cubic mesh of points which encompasses aligned
molecules by means of suitable probes can explain variations in binding affinities or biological activity
profiles for a series of congeneric compounds. In fact, the modelling efficiency of electronic and steric
potentials in the molecular environment is strictly affected by the selection of a suitable atomic
probe (usually positively charged sp3 carbon atom) and superimposition applied following the
putative pharmacophore hypothesis. Consequently, the distribution of potential values on mesh
points relies on the molecular coordinates that is a decisive factor controlling the value of atomic
partial charges. The resulting potential energies at each lattice point can be depicted graphically
as three-dimensional coloured contour pattern illustrating the spatial areas, where steric hindrance
and/or charged substituents enhance or diminish the binding affinity. A conventional imitation of
the molecular boundaries with masking explicit shape information using the regular cubic grid lattice
and/or molecular surface can be helpful in explaining pharmacological effects; therefore a number of
alternative CoMFA-like protocols have emerged recently as well.
3.2. CoMSA Analysis
Comparative molecular surface analysis (CoMSA) is a data processing tool based on
two-dimensional topology composed of a single neuron layer typically arranged into a hexagonal
or rectangular array of nodes with unsupervised learning procedure [32]. The winning and
neighbourhood distances precisely specify mutual relations between neurons in the network.
The presented m-dimensional input vector xs = (xs1, . . . , xsm) is distributed between neurons according
to similarity/correlation weight criteria, where similar inputs are located in the same or proximal
nodes. A typical competitive Kohonen (KNN) procedure is based on the comparison of the input
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vector with the corresponding m-element weight vector wi = (wi1, . . . , wim) that describes each neuron
in order to detect the winning one (outC), into which a particular input will be projected. The winning
neuron is selected by the optimization of the Euclidean distance between weight (w) and vector (x)
according to the following formula:
outC = min[∑mi=1
(
xi − wij
)2
] (1)
where j = 1, . . . , n refers to a particular neuron, n refers to the number of neurons, m is the number of
weights per neuron and s indicates a particular input.
In the winner takes most (WTM) methodology, the weights of the winning neuron and its
neighbours are then modified to resemble and subsequently attract similar input vectors. While the
next input vector is being presented to the network, the entire procedure is repeated. As a matter of
fact, self-organizing neural mapping (SOM) is considered as a nonlinear projection tool, which reduces
the dimensionality of the input object, e.g., converts 3D objects to 2D, while preserving the topological
relationships between the input and output data. Moreover, the trained network can be employed for
projections of the specified molecular property prescribed to the input vector with the creation of the
planar colour-coded clustering pattern called a feature map. In consequence, the SOM algorithm was
used to generate an electrostatic potential map as a two-dimensional topographic pattern receiving
the input signals from points sampled randomly at the molecular surface. In such application,
the specification of the closest neighbour and then projection of signals into this particular neuron
is based on the comparison of each 3-dimensional input vector consisting of x, y, and z coordinates
with a 3-element weight vector describing each neuron. The knowledge concerning the shape of
the certain molecular surface (template) encoded in the weights of the trained Kohonen network
can be used for processing signals coming from the surface of other molecule(s) (counter-template)
providing a series of comparative SOM maps to compare/contrast superimposed molecular geometry.
A wide range of SOM applications for the compression, classification and visualization of structural
data has been described in chemistry, in particular, for two-dimensional mapping of electrostatic
potential on three-dimensional molecular surfaces or partial atomic charges for atomic molecular
representation [33]. The fuzzification of the molecular representation that improves the compound’s
superimposition seems to be of special interest due to a prospectively better description of binding
affinity to a putative receptor structure.
3.3. PLS Analysis with Iterative Variable Elimination
The partial least squares (PLS) method generates a relationship between dependent variable
Y and an ensemble of descriptors (independent variables) X expressed briefly in the form of the
following formula:
Y = Xb + e (2)
where b is a vector of regression coefficients and e is a vector of errors.
The obtained data were centred and processed by the PLS analysis with the construction of models,
the complexity of which was approximated based on the leave-one-out cross-validation procedure
(LOO-CV) [34]. A cross-validated leave-one-out q2cv value for the assessment of the model performance
is measured using the following equation:
q2cv = 1− ∑
m
i (obsi − predi)2
∑mi (obsi −mean(obsi))2
(3)
where obs is an assayed value; pred is a predicted value; mean is the mean value of obs, and i refers to
the object index, which ranges from 1 to m.
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The standard deviation of the error of prediction (SDEP) and q2test parameters were estimated to
evaluate the quality of external predictions as follows:
SDEP =
√
∑ni (predi − obsi)2
n
(4)
q2test = 1−
∑ni (obsi − predi)2
∑ni (obsi −mean(obsi))2
(5)
where n is the number of objects in the test set.
Redundant variables can deteriorate the outcomes of regressive analysis; therefore, a reduction
in the number of uninformative variables might considerably improve PLS models. Despite the
fact that variable elimination in PLS modelling is a complex issue, a few algorithms have been
introduced recently, e.g., iterative variable elimination (IVE-PLS) which was successfully employed
in multidimensional (mD-QSAR) methods [35–37]. The iterative IVE-PLS procedure is used in the
current calculations as an enhancement of the single-step UVE algorithm for identification of variables
to be eliminated [38]. Briefly, the whole algorithm is composed of the following stages:
Stage 1. Standard PLS analysis with LOO-CV to assess the performance of the PLS model;
Stage 2. Elimination of the matrix column with the lowest abs(mean(b)/std(b)) value;
Stage 3. Standard PLS analysis of the new matrix without the column cancelled in stage 2;
Stage 4. Recurrent repetition of stages 1–3 to maximize the LOO q2cv parameter.
3.4. PCA Analysis
The mapping of molecular diversity forming the infinite chemical space (CS) into the
corresponding biological or property space generally requires multi-dimensional descriptor
representations [39]. A specified molecule might be represented by a set of structural (S) and
physicochemical (P) properties organized in a vector which represents an object in the CS.
The molecular distribution of empirically (factual chemical space, FCS) and virtually (virtual chemical
space, VCS) generated compounds might be graphically investigated using, e.g., a linear projection
procedure called principal component analysis (PCA). The restrained set of orthogonal descriptors
(principal components, PCs) being a linear combination of weighted input vectors forms a basis
for lower-dimensional space, while maintaining the input space topology [40]. The projection of
multi-dimensional objects into two/three-dimensional PC space enables the diversity exploration by
calculating distance metrics. The PCA model decomposes information contained in the data matrix
into principal components—scores and loadings. The score matrix contains information about any
similarities among the data objects, while the loading matrix allows similarities among the variables
and their role in the construction of the given principal component to be studied. The PCA model with
f principal components for a data matrix X can be presented as follows:
X = TPT + E (6)
where X is a data matrix with m objects and n variables, T is the score matrix with dimensions (m × f ),
PT is a transposed matrix of loadings with dimensions (f × n) and E is a matrix of the residual variance
(m × n) that is not explained by the first f principal components. The PCA usually reduces the number
of variables while retaining most of the original information.
3.5. Artificial Dipeptide Receptor Library Synthesis
The artificial dipeptide receptor (ADR) arrays were synthesized on cellulose plates according
to the SPOT methodology with the modified structure and properties of the linker [41]. Amino acid
blocks and gating acids were selected in order to provide a fairly robust measure for diverse ADR
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constructs that should imitate real active residues of receptors; therefore, a randomized dipeptide
library was applied, which allows systematic (all natural amino acids at the N-terminal position) study
of the effect of the peptide fragment structure on the binding to/interaction with biologically active
compounds. The library of molecular receptors was prepared from a pi-acceptor, pi-donor aromatic
rings, peptide and lipid fragments. It was found in previous studies that the presence of all of these
was vital for the binding of ligands [42]. Each copy of the array was prepared on a separate page.
The library was synthesized using an automated procedure (Scheme 1) starting with the immobilization
of 2,4-dichloro-6-methoxy-1,3,5-triazine (2) (used as a pi-acceptor) on 26 cellulose membranes that were
used as solid supports 1. The incorporation of m-phenylenediamine (4) (introduced as a pi-donor)
generated a relatively rigid nucleophilic scaffold, which enabled further surface modification by
acylation of compound (5) with N-protected amino acids. The peptide fragment was synthesized
under classic solid phase peptide synthesis conditions using Fmoc protected amino acids (6) and
4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium tetrafluoroborate (DMT/NMM/BF4) as
a coupling reagent [43]. Six membranes were used in the tests to monitor the progress of the
synthesis. Twenty membranes were used for the preparation of the randomly designed array of
120 dipeptides N-acylated with heptanoic acid and/or decanoic acid. Side chain functional groups
were protected by acid labile protecting groups. After each coupling stage, the Fmoc group was
cleaved by the treatment with a 25% solution of N-methylpiperidine in DMF. Heptanoic acid (H) and
decanoic acid (D) were activated with 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium
4-toluenesulphonate (DMT/NMM/Tos) before being used for the N-lipidation of the immobilized
peptides. Side chain protecting groups were removed using the standard procedure that includes
the treatment of functionalized cellulose with TFA in the presence of triisopropylsilane (TIS) [44].
The array of artificial peptide receptors (9) was synthesized in this way. The structures of the ADR
library (9) are presented in Table S2 of Supplementary Materials. All ligand docking experiments were
performed using a brand new array of receptors.
The details of synthetic procedure are given below. Immobilization of 2,4-dichloro-6-methoxy-1,
3,5-triazine (DCMT): 10 sheets (10 × 10) of Whatman-Chr 1 filter paper were immersed in 1 M
NaOH (40 mL) and gently shaken for 15 min. An excess of solution was removed, then the wet
paper sheets were soaked in suspension of finely grounded sodium bicarbonate in 1 M solution
of 2,4-dichloro-6-methoksy-1,3,5-triazine (DCMT) (6.8 g) in THF (40 mL) and again gently shaken
for 60 min at rt. Then cellulose sheets were washed with THF (2 × 30 mL), acetone (2 × 30 mL),
acetone:H2O 1:1 (2 × 40 mL), acetone (2 × 40 mL) and with DCM (30 mL), than left to remove the
remaining solvent and dried in a vacuum desiccator. Elemental analysis: for cellulose: %N 0.00–0.05,
%Cl 0.01–0.05, after DCMT immobilization found: %N 3.64, %Cl 2.66. The loading of the cellulose
sheets with triazine was calculated from elemental analysis data. The surface loading was calculated
according to nitrogen content 31.9× 10−6 mol (N)/cm2, which was equivalent to NLs = 10.6×10−6 mol
(triazine)/cm2 and ClLw = 0.75 mmol (Cl)/1 g, giving equivalent to ClLs = 9.2×10−6 mol (Cl)/cm2.
Immobilization of m-phenylenediamine: The cellulose sheets functionalized with DCMT were
immersed in 1 M solution of m-phenylenediamine (4.3 g) in THF (40 mL) and gently shaken for
24 h at rt. Then sheets were washed successively with THF (2 × 20 mL), DMF (2 × 20 mL) and
THF (2 × 20 mL) again and dried in the vacuum desiccator. SPOT synthesis of N-lipidated peptides
on the cellulose: The peptides were synthesized on an automatic synthesizer ResPep SL by Intavis
using a modified SPOT procedure [45]. The 0.56 M solutions of all Fmoc-protected natural amino
acids were prepared in (N-methyl-2-pyrrolidone) (NMP). As a coupling reagent, a 0.5 M solution of
4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium 4-toluenesulfonate (DMT/NMM/TosO−)
in DMF was used. As a base, 2 M NMM in DMF was used. To remove Fmoc protecting group, 25%
piperidine in DMF was used. The first synthetic cycle included: Preactivation: 6 min, for each spot:
0.15 µL solution of coupling reagent; 0.073 µL solution of NMM; 0.17 µL amino acid (Fmoc-Ala-OH,
Fmoc-Pro-OH, Fmoc-Phe-OH); 0.003 µL NMP; Coupling: 2 × 3 min; for each coupling, 0.198 µL of
the preactivated solution was used. The second synthetic cycle included: Fmoc-group deprotection
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(2 × 10 min, dispense volume: 500 µL); Preactivation: 6 min, for each spot: 0.15 µL solution of
coupling reagent; 0.073 µL solution of NMM; 0.17 µL amino acid (all natural amino acids); 0.003 µL
NMP; Coupling: 2 × 3 min; for each coupling, 0.198 µL of preactivated solution is used. The third
synthetic cycle included: Fmoc-group deprotection (2 × 10 min, dispense volume: 500 µL); Coupling:
1 × 7.5 min; for each spot were used: 0.3 µL NMP and 0.15 µL of 0.25 M solution of triazine esters of
heptanoic acid and decanoic acid in DMF:NMP (1:1). Deprotection of the side chains of dipeptides:
Modified cellulose membranes were treated with a mixture consisting of 50% (v/v) trifluoroacetic acid
in DCM (200 mL) with 3% (v/v) water and 2% (v/v) trisopropylsilane for 5 h. Then the membranes
were washed with DCM (2 × 100 mL), EtOH (2 × 100 mL) and dried in a vacuum desiccator. Buffering
of cellulose membranes: The modified cellulose membrane was buffered with phosphate buffer pH 7.0
(200 mL) for 30 min. Then, celluloses were washed with water (2 × 200 mL) and a mixture MeOH:H2O
(1:1) and dried to constant weight in the vacuum dessicator. During the synthesis, two identical
libraries were prepared on each functionalized sheet, after splitting each sheet for two parts, one of
them was treated with the active substance and then with the reporter dye (Brilliant Black), the second
one was treated with the reporter dye only.
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3.6. Anticancer Compounds Docking
The dot arrays consisting of a library of artificial peptide receptors were buffered (phosphate
buffer, pH = 7) and conditioned in a vacuum desiccator overnight before being immersed into a
gently shaken solution (25 mL) of anticancer active ligands in MeOH (25 µmol/100 mL) for 15 min.
The library was then washed four times with MeOH (50 mL) and dried in the vacuum desiccator.
After conditioning, the library was treated with a 25 mL solution of the reporter dye (Brilliant Black,
100 µmol/100 mL MeOH) for 15 min. Any excess of the reporter dye was removed by successive
washings with methanol (5 × 50 mL), which were continued until a colourless washing solvent was
obtained, after which they were dried in the vacuum desiccator. All of the structures were scanned in
the 24-bit RGB colour space. The resulting scans were converted into 256-bit grey scale and processed
using the Image Quant program. The average value of grey coloration was determined for all of the
discs in library in this way. Ability of molecular receptors to interact with colorless active substances
(ID) was calculated as difference in intensity of coloration by reporter dye (IDrd) and intensity of
coloration with active substance and then with reporter dye (Brilliant Black) (IDa).
ID = IDrd − IDa (7)
where: ID—intensity of ligand binding measured by coloration in 256 bit gray scale, IDrd—intensity of
coloration with reporter dye, IDa—intensity of dyeing after treatment of disk with active substance
and subsequently with reporter dye. Thus, the ID is proportional to the amount of ligand bound to
the receptor.
3.7. Binding of Anticancer Active Ligands to Molecular Receptors Pockets
The result of docking of compounds with antitumor activity into the molecular receptor binding
cavities is shown in the form of an intensity binding map (Figure 4b). The research began with
the search for molecular receptors that form strong complexes (no displacement from the binding
cavity under the action of a reporter compound) with all docked derivatives. This assumption was
due to the fact that the common element of all tested compounds (with exception of compounds
15 and 20) is the presence of a methoxy substituent and the N-(2-chloroethyl)piperazine moiety
on the triazine ring. Finding molecular receptors binding all compounds can provide information
about the amino acid structure of the peptide receptor fragment responsible for the formation of
molecular targets. For a sublibrary containing alanine as a C-terminal amino acid, receptors binding
all docked compounds were RA, KA, SA, TA, YA, IA, LA, VA and PA. In all cases, the selected
receptors were lipidated at the N-terminal position with n-decanoic acid residue. For a sublibrary
containing phenylalanine at the C-terminal position, receptors able to interact with all docked ligands
were n-heptanoyl-AF, n-decanoyl-PF, n-decanoyl-KF, n-decanoyl-TF, n-decanoyl-IF, n-decanoyl-YF,
n-decanoyl-LF and n-decanoyl-VF. In the case of a sublibrary containing proline in the C-terminal
position, the following receptors were selected: NP, TP, GP, VP, IP. In all cases, the generated receptors
were lipidated at the N-terminal position with an n-decanoic acid (D) residue.
3.8. Model Builder & Molecular Modelling
The same laboratory was employed to specify inhibitory activity data (IC50) to eliminate
potential data noise that might be introduced by pooling of data sets coming from various sources.
The structures and the in vitro efficiency of derivatives containing the N-chloroethyl-piperazine
scaffold attached directly to the 1,3,5-triazine moiety are introduced in Table 1 and Figure 9, respectively.
The CACTVS/csed molecular editor was used to specify the constitution of the respective compound
models [46]. The spatial geometry of molecules was produced using the 3D generator CORINA [47].
The (inter)change file format converter OpenBabel was applied to convert the chemical data [48].
The principal components of the modelling studies were conducted with the usage of the Sybyl-X
2.0/Certara software package running on a HP workstation with Debian 6.0 operating system [49].
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The standard Tripos force field (POWELL conjugate gradient algorithm) with 0.01 kcal/mol energy
gradient convergence criterion and a distant dependent dielectric constant was used to optimiz
the initi l geometry f each compound (MAXMIN2 module). The Gasteiger-Hückel procedure
impleme ted in Sybyl for the electrostatic potential calculations was initially employed to calculate th
partial atomic charges. The trial alignments are typically defined to systematically span the common
scaffold of the analysed compounds; therefore, o 15-ord red atom trial alignme t on molecule 2
according to the ctive alogue approach (AAA) was selected to cover the entire bonding topology
in the maxi al common structure (c njugated triazine/piperazin /chloroethyl motif) by atom FIT
method based on the matching of atom positions between t e orresponding atom pairs (1–15). The sp3
hybridiz d carbon probe atom with the charge of +1 and 0 a d hydrogen as a probe atom with th
ch rge of +1 were used to calculate the electrostati and teric fields. The CoMFA grid spacing was
2.0 Å for all Cartesian dimensions within the defined region of the 3D lattice, which extended beyond
the van der Waals envelopes of all molec les by at least 4.0 Å. N -covalent int raction fields were
sp cified at ach intersection o the regularly spaced grid of points. For each molecule, energies with
the total of 1820 grid points were calculated with 2 Å spacing in a 14× 10× 13 lattic . All colum s with
energy variance less than 2.0 kcal/mol were discarded by setting the sigma parameter to 2.0 kc l/mol
to reduce d ta nois . Both st ric/electrostatic energies with a alue greater than 30.0 kc l/mol were
truncated t a tentative value of 30.0 (default cutoff). T SAMPLS method with standard internal
a d external valid ti techniques was used to determine the statistical ind x of th model predictive
power describing the v riations in C MFA interaction fields (independent variabl s) and ch nges
in activity (dependent variable). The SONNIA software was employed in the CoMSA analysis to
simulate 20 × 20 to 50 × 50 SOMs with the winning distance (md) varyiing in the range of 0.2–2.0.
The Cartesian coordinates of molecular surfaces for superimposed molecules were processed by the
SOM network to form a two-dimensional map of electrostatic potential—the most active analogue
2 was used to form a template molecule [50]. The output maps were subsequently transformed to a
400- or 2500-element vector which was processed by the PLS method implemented in the MATLAB
programming environment in correspondence with the CoMFA analysis [51].
4. Conclusions
The general pattern of the anticancer compounds comprises the N-(2-chloroethyl)piperazine
moiety and a methoxy substituent on the triazine ring. In our case, almost all investigated compounds
contained two amino substituents mimicking the structure of 2,4,6-amino-1,3,5-triazine derivatives
with various amino substituents; therefore, the following chemotypes can be distinquised: derivatives
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containing aromatic amine residues, aliphatic amines, amino acid residues, dipeptide derivatives and
derivatives containing two moieties N-(2-chloroethyl)piperazine and aromatic amine residues or the
methoxy substituent. Moreover, the examined molecules can also be subdivided in relation to the
hydrophobicity and hydrophilicity. The pharmacophore properties of a new series of potential P2X
inhibitors using a coupled neural network and the IVE-PLS method were examined in the ligand-based
comparative molecular surface analysis. The observed inhibitory potency was correlated with surface
descriptors regarding multiple training/test populations. In particular, some regions with suggested
unfavourable contribution appear in the close proximity to the negatively charged oxygen atom and
hydrogens of the metoxy group directly attached to the triazine motif. The importance of the area
occupied by the positively charged hydrogen atom bonded to the nitrogen atom was demonstrated as
a significant factor interacting non-covalently with the macromolecular site (hydrogen bond donor).
Moreover, the PCA procedure was employed for the set of Dragon and Sybyl descriptors to analyse
the dataset (dis)similarity. A focus was made on the interpretation of noticeable variations in the
potential selectiveness of individual inhibitor-receptor interactions due to their physicochemical
properties; therefore, the library of artificial receptors was designed and examined. The resulting
library response to individual inhibitors was arranged in the array, preprocessed and transformed
by the PCA and PLS procedures. A dominant absolute contribution of Glu attached to heptanoic
gating acid and Phe bonded to the linker m-phenylenediamine/triazine scaffold to PC1 was revealed
by the PCA analysis. Comparable results were obtained while correlating the ADR response with
experimental activity data. The IVE-PLS procedure indicated receptor systems with predominant
Pro bonded to the linker and Glu, Gln, Cys and Val directly attached to the gating acid. The direct
specification of Glu/Gln residues in ligand binding suggests the potential involvement in the hydrogen
bonding, for instance, with hydrogen attached to the nitrogen atom as indicated in the CoMSA study.
Val contributes to the hydrophobic environment of the binding pocket, while Phe can interact with the
ligand aromatic ring via pi-stacking phenomena. Interestingly, substituting Gln with Cys increases the
P2X receptor sensitivity due to the potential generation of disulfide bridges important for the gating
mechanism. The proposed comprehensive ligand-based and simplified structure-based methodology
allows the in-depth study of the performance of peptide receptors against the tested set of compounds.
In particular, an insight into the selectivity of the library can be gained, while increasing the number of
amino residues attached (polypeptide population), and therefore, it will be easier to indicate possible
new directions towards intelligent drug delivery systems.
Supplementary Materials: The supplementary material is available online. Table S1: Molecular descriptors
calculated with Sybyl software, Table S2: Position on cellulose sheet and structure of array of artificial peptide
receptors, Figure S1: Projection of variables on plane defined by first and second loadings for Dragon (a) and
Sybyl (b) parameters.
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